trending Market Intelligence /marketintelligence/en/news-insights/trending/Cz7K_AkO9zY2FzIT4jVi_w2 content esgSubNav
In This List

Sanofi nominates director to Regeneron Pharmaceuticals board

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Sanofi nominates director to Regeneron Pharmaceuticals board

Regeneron Pharmaceuticals Inc. added Tony Coles to its board.

The director was nominated by Sanofi, which owns 21.9% of the company, according to S&P Capital IQ data.

Coles is the chairman and CEO of Yumanity Therapeutics.